Array analysis for T-cell associated cytokines in gingival crevicular fluid: Identifying altered profiles associated with periodontal disease status by Koshy, Bindhu et al.
 Array analysis for T-cell associated cytokines in gingival crevicular fluid; 
identifying altered profiles associated with periodontal disease status 
 
Bindhu Koshy, Jeremy S Rees, Damian DJJ Farnell, Xiao-Qing Wei, Rachel J 
Waddington* 
 
School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Heath Park, 
Cardiff, UK. 
 
* Corresponding Author: Professor Rachel Waddington, Oral and Biomedical Sciences, 
School of Dentistry, Heath Park, Cardiff University, Cardiff, CF14 4XY, UK.  
Tel: +44(0)29255 10647;  email: waddingtonrj@cardiff.ac.uk 
 
Short title: Cytokine profiles in GCF 
 
Key words: T-cells, cytokines, gingivitis, aggressive periodontitis, chronic periodontitis, 
gingival crevicular fluid 
  
Abstract 
Objective:  Cytokine networks regulate innate and adaptive immune responses, which in turn 
are recognised to direct the progression or arrest of periodontal disease. This study aimed to 
compare the profile of seven cytokines implicated in regulating T-cell networks in gingival 
crevicular fluid (GCF) samples with differing classification of periodontal status. 
Methods: GCF samples were collected from patients with strong clinical evidence for chronic 
periodontitis, aggressive periodontitis, gingivitis or no gingival inflammation.  Cytokines IL-
6, IFN-ɣ, IL-4, IL-2, IL-17A, IL10 and TNFα were measured in each sample using a 
commercial cytometric bead array assay.  Descriptive statistics were used to indicate central 
tendency, data scatter and analysis of variance for each cytokine concentrations between 
respective patient groups.  Heat maps with dendrograms were produced to visualise 
hierarchical clustering and trends within the data.  
Results: Median concentrations for all cytokines analysed were highest for gingivitis samples 
and lowest for aggressive periodontitis samples.  The median concentration of IL-6 in gingivitis 
samples was observed to be 10.5 fold higher (~17300 pg/µl) than IL-6 in aggressive 
periodontitis samples (~1600 pg/µl). Median concentrations of IL-10, IL-17A and TNFα were 
also 2-2.2 fold higher in gingivitis samples compared to aggressive periodontitis. 
Conclusions: Descriptive statistical analysis noted raised concentrations of IL-6, IL-17A and 
TNFα associated with gingivitis; pro-inflammatory cytokines usually associated with 
periodontal tissue destruction, including bone.   Our results would suggest that these cytokines 
can additionally provide protective roles in preventing progression to advanced forms of 
periodontal disease.  Potential for how these cytokines contribute to providing this role is 
discussed.  
Clinical significance:  Defining the roles for the many cytokines involved in the pathogenesis 
of periodontal disease is far from complete.  Consequently the results of this study serve to 
evidence proposals that cytokines can exhibit both pro- and anti-inflammatory effects, which 
is dependent on the signalling environment within which they exist and the antagonizing or 
modifying actions of other cytokines. Whilst future research is necessary to explore 
mechanistic action, our study contributes new knowledge suggesting that IL-6 and IL-17A can 
provide roles in stabilising the lesion to limit disease progression, which does not preclude 
alternative roles in promoting periodontal bone loss in advanced forms of disease progression, 
which is also documented in the literature.    
Introduction 
Periodontal diseases encompass a group of inflammatory diseases that have recently been re-
classified to recognize the complex poly immuno-inflammatory nature of the disease pathology 
(reviewed by1).  Gingivitis is hence defined as involving mild inflammation of the gingival 
tissues that may be plaque induced, modified by systemic factors, or initiated by specific 
bacterial species.  Periodontal disease associated with extensive tissue destruction is classified 
as either chronic periodontitis involving slow to moderate rates of disease progression, which 
is modifiable by the presence of local risk factors such as smoking and stress; or aggressive 
periodontitis characterised by rapid loss of attachment and alveolar bone, and usually 
associated in patients under 30 years old.  Various epidemiological studies have broadly 
suggested that prevalence of gingivitis can be considered high, affecting greater than 75% of 
any population2.  Although precise data is difficult to obtain there is a consensus that only 5-
15% of patients continue to develop chronic forms of periodontitis2, whilst the prevalence of 
aggressive periodontitis is between 0.1 – 5%, which additionally appears to be ethnicity 
dependent3.  Such trends in the data suggest that subgroups of patients, as yet unidentified, are 
susceptible to develop more severe forms of periodontal disease and the distinctive patterns of 
tissue destruction observed between gingivitis, chronic and aggressive periodontitis would 
suggest that differences in cellular and molecular pathogenic mechanisms exist between the 
disease classifications.     
Within all forms of the disease, a dysbiosis in the natural microflora leading to the release of 
virulence factors derived from bacterial pathogens in the gingival sulcus, results in activation 
of immuno-inflammatory host responses within the surrounding periodontal tissues4,5,6. The 
inflammatory response is characterised by the infiltration of neutrophils, macrophages and 
leukocytes which are intended to be protective by aiding in the resolution of inflammation and 
halting disease progression.  Within this scenario T-helper cells (Th1, Th2 and Th17) and 
regulatory T-cells (Treg) are recognised to play a key roles. These T-cell subpopulations derive 
from the activation of naïve CD4+ T-cells with the cognate bacterial antigen.  In addition, a 
complex interplay of various pro- and anti-inflammatory cytokines and co-stimulatory signals 
act either to induce or to inhibit differentiation to the respective subpopulations, defining the 
final phenotypic nature of the developing T-cell.  Subpopulations produced are described to 
exhibit either beneficial or detrimental effects and thus the balance between 
Th1/Th2/Th17/Treg cells is important in directing tissue destruction or in preventing it 
(reviewed by7,8,9). 
Numerous studies have shown some success towards identifying clear involvement for Th1, 
Th2, Th17 and Treg cells, although the precise contribution for how each cell subset stimulates 
periodontal tissue destruction is unclear.  Studies in mice, involving the induction of 
periodontal tissue destruction by known periodontal pathogens, have demonstrated a prominent 
role for CD4+ cells in mediating alveolar bone destruction (reviewed by 7).  However, it has 
been difficult to clarify which subset plays the greater pathogenic role. A plethora of animal 
studies have proposed that Th1 cells are associated with a stable lesion, whereas Th2 cells are 
associated with the progressive lesion6.  Conversely, clinical studies have also suggested that 
raised levels of Th1 cells occur in diseased tissues, whereas other studies identify as yet 
undefined roles for both Th1 and Th2 cells in periodontal disease.  Mechanistic understanding 
is further complexed when considering the additional involvement for Th17 and Treg cells6.   
Mice deficient for interleukin (IL)-17A, a pro-inflammatory cytokine produced by Th17 cells, 
were more susceptible to periodontally-induced alveolar bone resorption, suggesting a 
protective role for this T-cell subset10.  This contradicts in vitro studies suggesting 
osteoclastogenic activity for Th17 cells11.  Likewise, human gingival biopsies from patients 
with gingivitis and periodontitis have identified the co-existence of both Th1 and Th212,13.  
However, the subset that is responsible for disease progression to more advanced forms of 
periodontitis is still controversial with contradictory results published14,15,16. Cytokines 
characteristic for Th17 cells (IL-17A, IL-17, IL-21, IL-22, IL-26) have been shown to be 
elevated in both the periodontal tissues and gingival crevicular fluid of patients exhibiting 
either periodontitis or gingivitis17,18,19,20. Several reports have also described increased 
infiltration of Treg cells in human gingival tissue associated with periodontal lesions18,21.  It is 
also recognised that the balance of T-cell subgroups formed also sits within a wider reciprocal 
signalling environment involving other cells involved in the immune response, including 
neutrophils, macrophages and B cells.  The activity of such cells is equally critical in dictating 
either resolution of inflammation leading to tissue repair or progressive tissue destruction7,8,9.  
Against this background of limited evidence, the aims of the present study were to identify a 
multi-array profile for a number of T-cell-related cytokines present within an individual sample 
of gingival crevicular fluid.  Samples were taken from patients stratified as presenting with 
either gingival inflammation, chronic or aggressive forms of periodontitis.  Results were 
compared to GCF samples from relatively healthy controls demonstrating minimal 
inflammation.   
 
1. Materials and Methods 
2.1 Recruitment of patients 
Ethical approval was provided by South East Wales Local Research Ethics Committee 
(reference number 08/WSE03/3), following Good Clinical Practice regulations and with 
informed consent obtained from each patient. A total of 40 patients, representing 10 patients 
with chronic periodontitis, 10 patients with generalised aggressive periodontitis, 10 patients 
with gingivitis, and 10 healthy subjects, were recruited from patients referred to the Restorative 
Clinic at Cardiff University Dental School. Exclusion criteria included pregnancy, medical 
conditions or medications that may influence periodontal health, intake of any antibiotic or 
anti-inflammatory drugs in the previous six months or a history of periodontal therapy in the 
previous six months. Patient recruitment was based on the clinical and radiographic criteria 
proposed at the 1999 International World workshop for classification of periodontal disease 
conditions22.  Thus for the study presented herein, the aggressive periodontitis group presented 
with attachment loss of greater than 6 mm affecting a minimum of six teeth; all subjects in this 
group were younger individuals below the age of 40.  The chronic periodontitis group presented 
with attachment loss in the range of 6-10 mm in 2-5 teeth, which was typically associated with 
substantial amounts of plaque and calculus and a radiographic indication of gradual horizontal 
bone loss; patients in this group represented a broader age range.  Gingivitis was associated 
with plaque-induced inflammation and demonstrated no evidence of attachment loss either 
clinically or radiographically.  The control group were essentially free of large deposits of 
plaque and inflammation of the gingival tissue. 
2.2 Sample collection 
GCF was collected from two sites per patient.  Considering that periodontal inflammation and 
tissue destruction is site specific4 samples represented independent collections.  Contaminating 
saliva was isolated from the collection site, supragingival plaque was gently removed and the 
tooth was air dried.  GCF was collected by capillary action into 2 µl capillary tubes (Drummond 
Microcaps, Drummond Scientific Co, Pennsylvania, USA), placed at the gingival margin for a 
period of 10 min and then immediately stored at -80°C until further analysis.  During collection, 
capillary tubes were renewed when full or blocked by plaque debris.  GCF samples were 
visually examined in the capillary tube and those tubes that did not contain a relatively 
translucent fluid expected of GCF, due to contamination with excessive blood were discarded.  
GCF volume was determined by measuring the proportion of the tube filled with fluid. 
2.3 Measurement of clinical parameters 
GCF was collected prior to clinical measurements, which may have increased exudate 
production. Clinical parameters were recorded by a single operator, using the Florida Probe 
with a computerised, pressure-controlled PASHA probe, that was calibrated for each patient 
assessment (Florida Probe Corporation, Gainesville, FL, USA.  Probing depths and recession 
were recorded at six points per tooth.  
2.4 Cytokine analysis of GCF fluid 
Cytokine levels in each GCF sample was analysed using a BD Cytometric Bead Array Human 
Th1/Th2/Th17 Cytokine Kit (BD Biosciences, San Jose, CA, USA.) according to the 
manufacturer’s protocol. Each GCF sample was expelled from the capillary tube, mixed with 
15 µL of assay diluent and centrifuged at 1000 g for 5 min to remove debris.  The recovered 
supernatant was adjusted to a total volume of 35 µL with assay diluent and mixed with 35 µL 
of bead mix containing bead populations coated with capture antibodies specific for IL-2, IL-
4, IL-6, IL-10, tumour necrosis factor (TNF)α, interferon (IFN)γ and IL-17A (prepared 
immediately beforehand) and 35 µL of phycoerythrin (PE) detection reagent.  Samples were 
incubated at 4ºC overnight in the dark and then re-equilibrated to room temperature for 1 h. 
700 µL of wash buffer was added to each sample, centrifuged at 200 g, for 5 min, and pelleted 
beads were re-suspended in 200 µL of wash buffer prior to flow cytometry.  Sample data was 
acquired using a BD FACS Calibur flow cytometer (BD Biosciences).  FCAP ArrayTM 
software was used to generate results.  Within this software standard curves were generated 
using standards supplied with the assay kit and unknown values were calculated from the linear 
region with a 20-5000pg/ml detection limit for each cytokine analysed. 
2.5 Statistical analysis 
Descriptive statistics and graphical methods were used to explore the data using the SPSS V20 
statistical software package. Medians, means and standard deviations were calculated. STATA 
V13 was used to produce dot plots of cytokine levels (pg per ml) as a function of periodontal 
status group (i.e. control, aggressive periodontitis, chronic periodontitis and gingivitis), and 
line plots of the mean and median values for each group were superimposed on these charts. 
Normality of data distribution for each cytokine was assessed via normal plots and the 
Kolgorov-Smirnov and Shapiro-Wilk tests of normality.  Due to non-normality of the data and 
/ or the presence of outliers for all cytokines, differences between periodontal status groups 
were examined using non-parametric ANOVA (i.e., the Kruskal-Wallis test) for each cytokine 
separately. Dunn’s post-hoc tests were employed after non-parameter one-way ANOVA in 
order to detect differences between specific pairs of groups. Statistical tests were carried out 
using GraphPad Instat V3.10. 
The median concentration (pg per ml) for each of the cytokines analysed within each of the 
respective periodontal status groups were graphically depicted as a heat map created by using 
the statistical software package R.  Hierarchical cluster analysis was performed to arrange the 
heat maps to indicate clustering of cytokine concentrations with respect to both cytokine type 
and periodontal status group.  Dendograms generated were incorporated into the resulting heat 
maps to indicate the degree of similarity in cytokine median concentration between data sample 
groups. 
 
 
 
 
2. Results 
3.1 Clinical data 
Patient and sample clinical data is presented in Table 1.   Two sites were analysed per patient, 
with 10 patients per group recruited.  Considering that periodontal disease is site specific4, 
samples were treated independently.  Although flow cytometry was attempted, cytokine levels 
could not be measured with any confidence for 11 samples in the control group because the 
sample volume was too small and the cytokine concentration was below the detection limit 
identified within the standard curve.  For samples collected from patients with gingivitis, 
chronic periodontitis or aggressive periodontitis, 3-4 samples were not analysed due to excess 
blood contamination which would have greatly influenced the calculation of cytokine 
concentration within the GCF exudate.  The GCF volume is thus provided in Table 1 only for 
samples analysed, which demonstrated a small increase in flow rates for samples collected from 
patients within the chronic and aggressive periodontitis clinical group (median 2.4 µl over a 10 
min collection time) compared to patients with gingivitis or relative healthy gingival tissue 
(median 1.6 µl / 10 mins and 2 µl / 10 mins respectively).  For all clinical groups the age range 
was similar and a gender balance between male and female patients was obtained.  Attachment 
loss was much greater for the two periodontitis groups, indicating a broad range of values.   
3.2 Measures of central tendency, spread of data and analysis of variance 
Individual results obtained from the cytokine array analysis were reported as pg per ml of GCF; 
making the assumption that the concentration of cytokine bathing the underlying periodontal 
tissues at the time of analysis was the same as the GFC released into the gingival crevice.  
Mean, standard deviation, and median cytokine concentrations were calculated for the control 
group, the aggressive periodontitis, chronic periodontitis and gingivitis groups (Table 2). The 
lowest concentrations were observed for IL-2, IL-4, and IL-17A whereas the highest 
concentrations were for IL-6 and IL-10.  Median and mean values also showed that the cytokine 
concentrations for the gingivitis group were highest for all cytokines analysed compared to 
concentrations for the control, chronic periodontitis and aggressive periodontitis.  Cytokine 
concentrations for the aggressive periodontitis group are lowest for all cytokines compared to 
the concentrations for the other periodontal groups.  A scatterplot of the data obtained for each 
periodontal groups is shown in Figure 1, with respective mean and median values overlaid.  
This graphical representation shows the non-normal distribution in a high number of the data 
sets within each periodontal group, particularly for the gingivitis and periodontal groups, with 
high value outliers evident.  Significant differences were identified between the gingivitis 
group and the aggressive periodontitis groups for cytokines IL-2 (P =0.004), IL-4 (P = 0.004), 
IL-6 (P = 0.035), IL-10 (P = 0.048), TNFα (P = 0.037), IFNɣ (P = 0.001), and IL-17A (P = 
0.001). No other significant differences between groups were demonstrated. 
 
3.3 Heat maps and cluster analysis 
Due to the skew in the data evident for many of the data sets, median values for each cytokine 
concentrations within each periodontal group were used for hierarchical cluster analysis.  Heat 
maps and tree-based dendrograms for hierarchical clustering are shown in Figure 2. The colour 
scales progress from blue that indicate low median cytokine concentrations, through green, 
yellow and to a beige colour indicating the highest concentrations.  The tree-based 
dendrograms indicate the data groups connected by lines; those groups connected at the bottom 
of the tree (drawn close to the heat map grid) demonstrate similar cytokine concentrations, 
whilst data groups at the top of the tree indicate the greatest difference.   Hierarchical clustering 
clearly identifies that the concentration of IL-6 is much higher compared to all other cytokines 
analysed.  Data presented in Table 2 confirms that IL-6 concentration was 10.5 fold higher for 
gingivitis samples compared with concentrations for aggressive periodontitis samples.  Lowest 
concentrations of IL-2, IL-4, and IFN were identified within the heat map and cluster together 
with greatest similarity for cytokine concentrations when compared to each other.  Analyses 
also suggest that there is little difference in the concentration of IL-2, IL-4, and IFN cytokines 
between chronic periodontitis, aggressive periodontitis and the control group. Again, slightly 
higher concentrations for these cytokines are detected in the gingivitis group. IL-10, IL-17A 
and TNFα form an additional cluster group for demonstrating a similar concentration to one 
another.  Concentrations of these cytokines are again notably 2-2.2 fold higher in the gingivitis 
group, with IL-10 concentration also high in the control group. Clustering is also found with 
respect to the different periodontal groups, shown in the dendrogram on the left-hand side of 
the heat map.  Gingivitis demonstrates the most dissimilar cytokine profile compared with other 
periodontal status groups.  Cytokine concentrations for the chronic periodontitis and the control 
group clustered together, where the cytokine profiles were broadly similar, although subtle 
differences were observed in the cytokine concentrations for IL-6 and IL-10. Cytokine levels 
are again found to be lowest for aggressive periodontitis which demonstrates the greatest 
dissimilarity compared with the gingivitis group. 
 
 
 
3. Discussion 
Using a commercial multi-array assay system, this study was successful in providing an 
analysis of seven T-cell relevant cytokines within individual GCF samples collected from 
patients with strong clinical evidence of gingivitis, chronic periodontitis or aggressive 
periodontitis or little inflammation (“healthy” control).  Representing an exploratory analysis, 
the data collected provides new information to demonstrate descriptive trends in cytokine 
concentrations that are of value to develop and support hypotheses relating to the role of these 
cytokines in the propagation or arrest of periodontal disease.  For all cytokines analysed in this 
study, the data indicates that GCF samples from sites with aggressive periodontitis had the 
lowest concentrations of cytokines, whereas gingivitis samples had the highest concentrations. 
Significantly, our results indicated raised concentrations of IL-6, IL-17A, IL-10 and TNF in 
gingivitis samples compared with more advanced forms of periodontitis, suggesting potential 
roles for these cytokines in preventing disease progression and resolution of inflammation.   
Whilst cytokine regulatory networks are complex and involve secretions from other immune 
and stromal cells, a number of cytokine activities relevant to T-cell activity have been proposed 
(reviewed by7,8,9); from which commercial cytokine array assays have been developed.  
Considering only those cytokines analysed within this study, Th1 differentiation is known to 
be accelerated by IL-2, leading to the secretion of interferon (IFN)-ɣ which promotes cell-
mediated immunity involving activation of macrophages, CD8+ T (cytotoxic) cells and NK 
cells; thus providing a defence against intracellular bacteria.  IL-2 and IL-4 promote Th2 
differentiation.  Th2 secretes IL-4, IL-6 and IL-10 to mediate humoral immunity, via activation 
of B cell proliferation and antibody production, and mast cell activation, the presence of which 
has been suggested as characteristic of a progressive lesion23.  Moreover, Th17 cells form in 
response to cytokines IL-1β and IL-6 and characteristically produce IL-17A, IL-17.  Th17 cells 
are proposed to protect against extracellular bacteria and fungi, which is not effective via Th1-
mediated immunity24. Inflammation is further controlled by Foxp3+ Tregs which suppress the 
activation, proliferation and effector function for a wide range of immune cells25.  
Differentiation of naïve T-cells into Tregs is supported by IL-2 and  they characteristically 
produce IL-108.  Within the assay used in this study TNFα represents a generic pro-
inflammatory cytokine produced by many cell types.  Although the cytometric bead array assay 
kit used in this study was developed commercially to study cytokines associated with regulating 
activity of T helper cells, this is placing a too simplistic viewpoint in the interpretation of the 
data we have obtained.  It is also important to note that many of these cytokines analysed are 
also produced by other host cells within an inflammatory environment.  A more expansive 
summary of cells producing these cytokines is reviewed by 26, the relevance of which is also 
indicated in the discussion below.   
Within this study, we have reported cytokine levels as a concentration (pg/ml), which we regard 
as equivalent to the concentration bathing the underlying periodontal connective tissues and 
thus a highly appropriate unit of measure to analyse the data.   In addition, it is recognised that 
periodontal disease is associated with variable periods of active tissue destruction, quiescence 
or repair, where the duration and intensity of active periods of tissue destruction will vary.  
Active tissue destruction is thus very difficult to predict, especially since defining disease 
activity relies on historical evidence27.  Consequently, data of this type invariably produces a 
skewed distribution, with outliers evident and this was observed within the data presented 
herein.  For this reason both means and medians have been provided.  However, medians 
provide a more robust “measure of centre” in the presence of outliers and so heat maps and 
cluster analysis where created using median rather than mean concentration values.  
Probably the most notable and striking observation identified within this study, is the 
differences in IL-6 concentration, which descriptive analysis and the heat maps / dendrograms 
indicated was highest in the gingivitis group, potentially suggesting roles in prevention of 
disease progression and resolution of inflammation.  Compared to gingivitis samples, we 
observed a 10.5-fold decrease in IL-6 concentration in GCF of patients with aggressive 
periodontitis, where rapid tissue destruction is clinically evident.  Again, when compared to 
median concentrations in gingivitis samples, 6.6- and 4.3- fold decreases in IL-6 concentrations 
were observed within the control and chronic periodontitis group respectively.  IL-6 is 
described as a pleiotrophic mediator, assigned roles both in mediating inflammation, bone 
tissue destruction, and also in regenerative processes28.  In rheumatoid arthritis IL-6 is ascribed 
prominent roles in promoting tissue destruction and disease progression29.  IL-6 is invariably 
associated in a local periodontal lesion during the initial stages of gingival inflammation, which 
is produced by Th2, along with a variety of other cell types including B cells, endothelial cells, 
dentritic cells, macrophages, stromal cells, osteoblasts, adipocytes, fibroblasts and 
keratinocytes following activation by microbial products, IL-1 and TNF26,30,31.  Within this 
clinical scenario, it is noted that IL-6 has also been proposed roles that aid resolution of 
inflammation during acute inflammation and aids in the transition from innate to acquired 
immunity28.  Scheller et al28 have put forward a hypothesis that IL-6 acts, along with a plethora 
of chemokines, to recruit neutrophils to the local site.  On entering the site of inflammation, 
the neutrophils then produce soluble IL-6 receptor (sIL6R) as a consequence of proteolytic 
cleave of the membrane bound precursor.  This brings about a switch between classic to trans 
IL-6 signalling route within the endothelial cells; changing endothelial phenotype from one 
that recruits neutrophils to one that facilitates recruitment and survival of monocytes and T-
cells32,33.  This change to IL-6 trans-signalling within neutrophils has also been proposed to 
induce neutrophil apoptosis, leading to their clearance28.  Although neutrophils have been 
recognised as important in bacteria clearance, over activity of neutrophils can cause tissue 
damage and it can prolong the duration and severity of inflammatory periodontal diseases34.  
Within this study, a raised concentration of IL-17A was also detected in GCF samples of the 
gingivitis group compared with other groups.  IL-17A is produced by Th17 cells, suggesting 
elevation in Th17 cells during acute phases of inflammation.  This also correlates with the 
raised concentrations of IL-6 in the gingivitis group, which, in combination with TGF directs 
differentiation of naïve T-cells towards a Th17 phenotype35.  IL-17A is also produced by 
macrophages, dendritic cells, mast cells and natural killer cells and elevations of all these cells 
have been associated with acute phases of gingival inflammation; cells which also all produce 
IL-6.   Recent studies have also renewed interest in ɣδT-cells which are also producers of IL-
17A and IL-6 along with IFNɣ and TNFα36,37.  Whilst representing a small proportion of total 
number of circulatory leukocytes within the body, ɣδT-cells are proposed to represent as much 
as 30% of leukocytes in inflamed ginigiva37 where they are described a sentinel cells in mucosal 
tissue where bacterial challenge is prevalent36. However, Th17 has also been show to produce 
Receptor Activator of Nuclear factor Kappa-Β Ligand (RANKL) that promotes 
osteoclastogenesis and thus promote bone resorption38.  IL-17 produced by Th17 cells has also 
been described to lead to increases in TNFα, IL-1 and IL-6 within the local environment, which 
stimulates further RANKL expression by the resident stromal cells39.  These proposed roles for 
IL-17 and IL-6 do not concur with the lack of bone loss within our gingivitis group of patients 
and thus would suggest that these two factors able to mediate osteoclast formation within the 
signalling environment created during gingivitis.   
This is not to say that IL-17A and IL-6 do not play a role in promoting bone loss within the 
cytokine environment associated with chronic and aggressive forms of periodontitis.  Triggered 
by a dysbiotic microbiome, an increase in Th17 cells and neutrophils has been reported 
associated with inflammatory periodontal tissue destruction and defects in these cells resulted 
in reduced bone loss40.   However, it is also noted that mice deficient for the receptor for IL-
17A were susceptible to bacterial induced alveolar bone loss, due to deficient neutrophil 
migration41. Some authors have reported elevated neutrophil counts in patients with 
generalized aggressive periodontitis42, although others have reported that neutrophil numbers 
in serum are similar in aggressive and chronic forms of periodontitis43.  Studies have also 
reported that deleterious superoxide production by neutrophils was raised in both resting and 
stimulated neutrophils collected from patients diagnosed with aggressive periodotitis44.  
Additionally, incubation of control neutrophils with P. gingivalis lipopolysaccharide and serum 
from patients with aggressive forms of periodontitis generated a higher deleterious response, 
compared with incubation with control serum45.  These studies would support a prime role for 
impaired neutrophil function in propagating aggressive forms of periodontitis42.  High or 
impaired neutrophil levels associated with aggressive periodontitis correlates well with the 
observation in this study for low concentrations of IL-6 within this patient group, assuming the 
hypothesis that high IL-6 levels effect neutrophil apoptosis (as proposed above). It is thus 
tempting to speculate that reduced concentrations of IL-6 and IL-17 associated with aggressive 
periodontitis may partially be responsible for persistent and enhanced neutrophil activity. 
Notably, our data also suggests that the anti-inflammatory cytokine IL-10 is also elevated 
within the gingivitis group compared to the periodontitis group.  The major source of IL-10 is 
considered to be Tregs, but it is also produced by other T-cells, macrophages, dendritic cells 
and B cells26.  IL-10 has been ascribed a wide range of functions in general immuno-
suppression, by inhibiting proliferation and pro-inflammatory cytokine production of a wide 
range of immune cells8 including and neutrophils46.  Most notably, IL-10 has been reported to 
inhibit IFNɣ production, supress Th1 and promote Th2 cell activity23. Within this study, 
although elevated concentrations of IL-10 were reported in both control and gingivitis samples 
there was not a reduced concentration for IFNɣ, although this may be because levels were 
generally low across all periodontal sample groups.  Treg cells are also proposed to inhibit 
osteoclastogenesis, mediated by cytokines TGF, IL10 and IL-447.   
A further striking observation was that the lowest concentrations of IL-6, IL-17A and IL-10 
were detected in the aggressive periodontitis group.  Indeed for all cytokines analysed, lowest 
concentrations were observed within the aggressive periodontitis GCF samples.  It is unlikely 
that this would infer that the producer cells for these cytokines are also low.  It is possible that 
the cytokines produced by immune cells within this periodontal tissue are either quickly 
consumed or cells became toleranced to bacterial stimulation, preventing the release of 
beneficial cytokines, changing the signalling environment to one promoting tissue destruction. 
Within our analysis there is little discernible change in the concentrations of IL-2 and IFNɣ, 
(secreted by Th1 cells) and IL-4 (secreted by Th2 cells) in GCF samples collected from 
advanced or chronic periodontitis compared with the control, suggesting little change in the 
ratio of Th1 / Th2 cells.  Considering the number of other cells producing these cytokines, this 
is a dangerous assumption.  Small but detectable rises in the concentration of these cytokines 
are noted within gingivitis.  Unfortunately, our data is unable to add to the extensive debate 
within the area6.   
 
 
Conclusion  
The results presented within this study serve to highlight the complex nature of cytokine 
signalling activity in dictating periodontal disease progression or resolution of inflammation. 
It is important to note that the data presented represents a cross-sectional study, measuring 
cytokine levels from an individual where progression of the disease to advanced forms or 
resolution of gingival inflammation is unknown. Defining markers for identifying susceptible 
patients has thus not been possible, which is better achieved through longitudinal studies.  
Notwithstanding this limitation, this study has been successful in identifying statistically 
significant changes in the concentrations of IL-6, IL-10 and IL-17A, which were all found to 
be highest in GCF samples collected from patients with inflammatory gingivitis, but were 
lowest in GCF associated with aggressive forms of periodontitis. In considering the immuno-
pathology of periodontitis, these observations would add support to those studies in the 
literature that suggest IL-6, IL-10 and IL-17A can collectively act to suppress and prevent 
extensive tissue destruction. It is likely that the protective roles these cytokines provide in the 
gingivitis lesion are due to the network of other cytokine with which they interact.   Our 
discussion above did not dismiss the ability of these cytokines to also promote periodontal 
tissue loss, particularly that of bone, as indicated within the literature. The lack of detection of 
these cytokines in associated with aggressive periodontitis may be because the cytokines are 
quickly consumed by the cells they are regulating.  However, as a pilot study, the analysis of 
seven cytokines in a single sample has allowed the growth of hypotheses for further functional 
studies to identify the potential multiple roles for each cytokine within a defined extracellular 
signalling networks.  This data is thus pertinent for supporting future studies in the field that 
aim to further elucidate the mechanism of periodontal disease or for supporting the 
development of therapies and in elucidating differing and possibly contradictory metabolic 
information content available when using cytokines as diagnostic biomarkers. 
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Table 1: Patient and sample characteristics following collection of clinical parameters  
 Control Gingivitis Chronic 
periodontitis 
Aggressive 
periodontitis 
 
Number of 
samples 
analysed 
 
 
 
9 
 
 
17 
 
 
16 
 
 
16 
 
 
 
Age (years) 
 
   
             Range 28-40 28-56 33-54 28-40 
             Median 
 
33.5 42.5 48.0 34.5 
 
Male / Female 
 
 
5/5 
 
5/5 
 
6/4 
 
4/6 
 
AL (mm)     
            Range 0 0-1 6-10 6-10 
            Median 
 
0 0 7 8 
 
GCF volume (l) 
    
            Range 1.25 - 3.3 0.8-2.6 1.25 - 4 2-4.7 
            Median 
 
2 1.6 2.4 2.4 
 
 
 
Table 2: Mean, median, and standard deviation (SD) of cytokine levels (pg per ml) for the 
control group, and the aggressive periodontitis, chronic periodontitis, and gingivitis groups. 
 
 
 IL-2 IL-4 IL-6 IL-10 TNFα IFNɣ IL-17A 
 
Control  
(n = 9) 
 
Mean 
 
1181.6 
 
1178.9 
 
5003.1 
 
2482.5 
 
1743.2 
 
944.1 
 
1720.0 
Median 925.3 917.5 2602.2 1913.0 1553.4 710.4 1507.1 
SD 727.7 757.2 5938.6 1913.1 843.8 626.8 1051.4 
 
 
Aggressive 
periodontitis 
(n = 16) 
 
 
Mean 
 
 
1407.5 
 
 
1327.2 
 
 
8735.9 
 
 
2768.3 
 
 
2090.8 
 
 
969.0 
 
 
1968.6 
Median 729.9 723.0 1637.7 1428.9 1434.8 565.8 1089.6 
SD 2723.9 2437.0 11173.5 3496.9 1763.4 1507.2 3558.9 
 
 
Chronic 
periodontitis 
(n = 16) 
 
 
Mean 
 
 
1093.1 
 
 
1098.0 
 
 
11263.6 
 
 
1827.2 
 
 
2452.3 
 
 
887.6 
 
 
1709.1 
Median 854.7 861.7 3950.5 1419.2 1563.3 688.5 1376.1 
SD 843.9 830.8 16257.7 1197.2 2484.2 639.2 1246.2 
 
 
Gingivitis  
(n = 17) 
 
 
Mean 
 
 
1398.5 
 
 
1401.8 
 
 
27184.6 
 
 
4118.6 
 
 
3816.9 
 
 
1133.7 
 
 
2173.9 
Median 1232.1 1191.4 17289.2 2759.6 3248.3 1017.3 2082.4 
SD 570.7 574.1 37736.8 4815.3 2780.1 456.3 834.3 
         
  
Figure legends 
 
Figure 1:  Cytokine concentrations within each patient group.  Results are presented as actual 
values depicted as scatter plots (data for individual GCF samples represented as open circle) 
with the mean (solid line) and median (broken line) vales overlaid.  Results indicate the 
continued trend for higher cytokine concentrations within the gingivitis group which was 
significantly different for IL-17A, IFNɣ, IL-2 and IL-4 when compared to aggressive 
periodontitis samples.  *** p<0.001 * p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 
Figure 2:  Heat map for relative comparison of median cytokine concentrations within each 
patient group.  Cluster analysis provides hierarchical ordering based on these cytokine median 
values.  Descriptive analysis indicates that cytokines IL-6, IL-17A, IL-10 and TNFα are present 
in much higher concentrations in samples collected from sites associated with gingivitis.  
Conversely, the analysis demonstrates low cytokine concentrations apparent in GCF collected 
from patient with aggressive periodontitis. 
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